Galleto, Lalaine .
HRN: 24-83-40 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/21/2024
CEFUROXIME 1.5GM (VIAL)
03/21/2024
03/21/2024
IV
1.5gm
LD
Stat Cs
Checking Final Appropriateness
03/21/2024
CEFUROXIME 1.5GM (VIAL)
03/21/2024
03/22/2024
IV
1.5gm
Q8 3 Doses
Sp Cs
Checking Final Appropriateness
03/21/2024
CEFUROXIME 500MG (TAB)
03/21/2024
03/27/2024
PO
500mg
Bid
Sp Cs
Checking Final Appropriateness